WHO Trial

• World Health Organization (WHO) Cooperative Trial

• Treated hypercholesterolemic men with Clofibrate

• 25% reduction in risk of non-fatal MI at 5 years

• 47% increase in noncardiovascular deaths at 5 years

Previous slide

Next slide

Back to first slide

View graphic version